Ribavirin/sofosbuvirLack of efficacy: 5 case reports

被引：0

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1833卷 / 1期

关键词：

D O I：

10.1007/s40278-020-87155-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：337 / 337

相关论文

共 50 条

[31] VismodegibLack of efficacy: 5 case reports [J].

Reactions Weekly, 2023, 1946 (1) :538-538

[32] CatequentinibLack of efficacy: 5 case reports [J].

Reactions Weekly, 2023, 1939 (1) :131-131

[33] TacrolimusLack of efficacy: 5 case reports [J].

Reactions Weekly, 2023, 1940 (1) :387-387

[34] AntineoplasticsLack of efficacy: 5 case reports [J].

Reactions Weekly, 2022, 1916 (1) :46-46

[35] AntineoplasticsLack of efficacy: 5 case reports [J].

Reactions Weekly, 2023, 1943 (1) :90-90

[36] OsimertinibLack of efficacy: 5 case reports [J].

Reactions Weekly, 2022, 1934 (1) :356-356

[37] AntifungalsLack of efficacy: 5 case reports [J].

Reactions Weekly, 2025, 2049 (1) :37-37

[38] AmiodaroneLack of efficacy: 5 case reports [J].

Reactions Weekly, 2021, 1877 (1) :25-25

[39] Multiple drugsLack of efficacy: 5 case reports [J].

Reactions Weekly, 2024, 2037 (1) :284-284

[40] Antineoplastics/hydrocortisoneLack of efficacy: 5 case reports [J].

Reactions Weekly, 2023, 1957 (1) :54-54

← 1 2 3 4 5 →